Top Markets
Coin of the day
Aeglea BioTherapeutics, Inc. Aeglea BioTherapeutics, Inc.

Aeglea BioTherapeutics, Inc.

AGLE
Rang în acțiuni #23495
Aeglea BioTherapeutics, Inc. is a clinical-stage biotechnology firm dedicated... Aeglea BioTherapeutics, Inc. is a clinical-stage biotechnology firm dedicated to creating human enzyme therapies for rare metabolic diseases. Their leading candidate, pegzilarginase, a recombinant human Arginase 1, is currently in the pivotal Phase III PEACE trial to assess its safety and effectiveness for treating Arginase 1 deficiency. Furthermore, the company is developing AGLE-177, a polyethylene glycol modified enzyme, which is progressing through Phase I/II clinical trials for homocystinuria. Their early-stage pipeline includes AGLE-325 for cystinuria, along with other ongoing research initiatives. Founded in 2013, the company was initially known as Aeglea BioTherapeutics Holdings, LLC, changing its name to Aeglea BioTherapeutics, Inc. in March 2015. It is based in Austin, Texas.
Preț acțiune
$19.30
Ultima sincronizare: 2023-12-26
Capitalizare de piață
$72.77M
Schimbare (1 zi)
6.22%
Schimbare (1 an)
0.00%
Țară
US
Tranzacționează Aeglea BioTherapeutics, Inc. (AGLE)

Categorie

Istoric al prețului acțiunii pentru Aeglea BioTherapeutics, Inc. (AGLE)
Cel mai mare preț de închidere: $17.81 pe 2023-12-01

Cel mai mic preț de închidere: $240.00 pe 2016-04-01
Istoric al prețului acțiunii pentru Aeglea BioTherapeutics, Inc. din 2016 până în 2026
Evoluția anuală a prețului acțiunii
An Performanță
2023 80.43%
2022 -90.79%
2021 -48.55%
2020 6.06%
2019 3.25%
2018 49.19%
2017 -3.90%
2016 0.00%
Prețul acțiunii pentru companii similare sau concurente
Companie Preț acțiune Variație 1an% Țara
$547.71 38.62%
US
$1.04K 58.06%
NL
$145.75 437.43%
US
$118.70 -15.60%
AU
$770.19 8.98%
CH